NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Tag: PR Newswire
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sun Communities, Inc. (NYSE: SUI) between February 28, 2019 and September 24, 2024, both dates inclusive (the “Class Period”), of the important February 10,…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited (“Capri” or the “Company”) (NYSE: CPRI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
The 50IU, 100IU and 200IU formulations cover aesthetic and therapeutic indicatons The strong partnership with Medica Group will boost Hugel’s expansion in the MENA SEOUL, South Korea, Jan. 21, 2025 /PRNewswire/ — Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha,…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Transocean Ltd. (“Transocean” or the “Company”) (NYSE: RIG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Integris Composites, Inc., a global leader in armor protection for the world’s elite military and police, says the new rapid response armor system is a first in an emerging category of Situational Armor. LAS VEGAS, Jan. 21, 2025 /PRNewswire/ — In a departure from a three-decade tradition…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
Dinner for Two and Romantic Accommodations for two MONTEREY, Calif., Jan. 21, 2025 /PRNewswire/ — Valentine’s Day is fast approaching, and Cupid’s arrows are flying; it’s time to wrap up plans for the perfect Valentine’s Day celebration. Give your special someone the gift of a romantic…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…